INSIGHTS ON UPSTREAM MANUFACTURING
-
![Asahi Kasei Bioprocess - Made In The USA]( "Asahi Kasei Bioprocess - Made In The USA")
Asahi Kasei Bioprocess - Made In The USADiscover how combining Japanese precision with American ingenuity creates reliable bioprocess filtration solutions built for consistent, batch-after-batch manufacturing performance.
-
![Microbial Expertise That Scales Globally]( "Microbial Expertise That Scales Globally")
Microbial Expertise That Scales GloballyWant consistency and control in microbial manufacturing? We combine decades of expertise, advanced automation, and global processes to deliver reliable, scalable fermentation performance.
-
![60-Seconds Of Science Scaling Success With Perfusion Manufacturing]( "Scaling Success With Perfusion Manufacturing")
Scaling Success With Perfusion ManufacturingInterested in improving cell viability in biologics manufacturing? See how perfusion processes help maintain healthier cell cultures by continuously removing waste products.
-
![GettyImages-1207997703-dog-animal-vet-veterinarian]( "How Integrated Molecule Innovation Is Transforming Vet Therapeutics")
How Integrated Molecule Innovation Is Transforming Vet TherapeuticsCell line development underpins modern animal health innovation, enabling production of targeted biologics and supporting integrated approaches that improve therapeutic precision, scalability, and treatment outcomes.
-
Reducing Variability In Gene Expression: Bottlenecks And Solutions5/26/2026
Gene expression variability in biologics comes from random gene integration and cell heterogeneity; advanced engineering and targeted integration improve consistency, stability, and productivity.
-
Cell Line Development: Faster Path To A Stable Master Cell Bank5/26/2026
Cell line development builds stable, high-yield cell lines and a master cell bank, enabling consistent, scalable biologics manufacturing through selection, characterization, and cryopreservation.
-
Revolutionizing Biopharma Manufacturing5/26/2026
Integrated platform boosts biologics manufacturing by raising protein yield, speeding timelines, and improving scalability via cell line development, process optimization, and data-driven design.
-
Enhancing Antibody Yields With N-1 Perfusion5/26/2026
N-1 perfusion improves antibody production by increasing cell density, optimizing media and conditions, boosting yields up to 4.5× while maintaining quality and reducing manufacturing time and costs.
UPSTREAM MANUFACTURING SOLUTIONS
-
![Hyclone]( "Increase Cell Culture Yield Without Increasing Aggregation")
Designed for CHO cell culture processes, the HyClone™ glycan supplement enhances galactosylation and maintains stable culture performance.
-
![1,200 Liter Precision Stainless Reactor]( "Used 1,200 Liter Precision Stainless Reactor")
Used 1200 liter Precision Stainless reactor, Hastelloy C276 construction, approximately 52" diameter x 33" straight side, dish top and bottom, rated 45 psi and full vacuum at 350 f internal, jacketed for 100 psi and full vacuum at 350 f, top entering off center .5 hp Lightnin agitator drive, 90 volt dc, 18" top manway, 1.5" bottom outlet, with forklift access, serial# 211929-3, national board# 9863, built 2002.
-
![pharma-manufacturing-GettyImages-2196233628]( "Quality At Scale: Biologics Development And Manufacturing")
886+ biologics batches. 12 commercial molecules. Proven scale-up from IND to commercialization. See how a global CDMO network protects quality at every stage.
-
![Bioreactor for cell culture-GettyImages-517653054]( "A Data Driven Approach To Mammalian Scale-Up And Transfer")
Mammalian scale‑up is vulnerable to subtle changes. Discover a mechanistic, data‑driven approach that uses cellular kinetics, modeling, and scaled‑down validation to help reduce transfer risk.
-
![biologics-GettyImages-2243791279]( "Raising The Bar On What's Achievable In Continuous Manufacturing")
Integrated perfusion and downstream processing reduce timelines without compromising quality, showing how continuous manufacturing is elevating yield, efficiency, and long-term stability.
